{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:51Z","timestamp":1761895551144,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1124\/dmd.112.049171","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T00:51:37Z","timestamp":1350694297000},"page":"170-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Importance of UDP-Glucuronosyltransferases 2A2 and 2A3 in Tobacco Carcinogen Metabolism"],"prefix":"10.1016","volume":"41","author":[{"given":"Ryan T","family":"Bushey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas F","family":"Dluzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.049171_bib1","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1158\/0008-5472.CAN-08-4143","article-title":"Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype","volume":"69","author":"Balliet","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.112.049171_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","article-title":"Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues","volume":"17","author":"Bi\u00e8che","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.112.049171_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0163-7258(89)90122-8","article-title":"UDP-glucuronosyltransferases","volume":"43","author":"Burchell","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.112.049171_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/FPC.0b013e328341db05","article-title":"Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis","volume":"21","author":"Bushey","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.112.049171_bib5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/jpet.112.198770","article-title":"Identification and functional characterization of a novel UGT2A1 splice variant: Potential importance in tobacco-related cancer susceptibility","volume":"343","author":"Bushey","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.049171_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FPC.0b013e3282f4dbdd","article-title":"Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines","volume":"18","author":"Chen","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.112.049171_bib7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/dmd.107.019406","article-title":"Glucuronidation of tobacco-specific nitrosamines by UGT2B10","volume":"36","author":"Chen","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.049171_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.108.045500","article-title":"Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction","volume":"74","author":"Court","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.112.049171_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1093\/carcin\/bgm164","article-title":"Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10","volume":"28","author":"Dellinger","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.112.049171_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.105.009100","article-title":"Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform","volume":"34","author":"Dellinger","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.049171_bib11","first-page":"1978","article-title":"Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes","volume":"62","author":"Fang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.112.049171_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"Gibbs","year":"2003","journal-title":"Nature"},{"key":"10.1124\/dmd.112.049171_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0306-3623(98)00114-1","article-title":"Glucuronidation: a dual control","volume":"31","author":"Gu\u00e9raud","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1124\/dmd.112.049171_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","article-title":"Tobacco smoke carcinogens and lung cancer","volume":"91","author":"Hecht","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/dmd.112.049171_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1042\/bj3400837","article-title":"Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase","volume":"340","author":"Jedlitschky","year":"1999","journal-title":"Biochem J"},{"key":"10.1124\/dmd.112.049171_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.112.192658","article-title":"Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity","volume":"342","author":"Jones","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.049171_bib17","first-page":"812","article-title":"Expression of the tumor suppressor gene Maspin in human pancreatic cancers","volume":"7","author":"Maass","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.112.049171_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(02)01522-8","article-title":"Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7","volume":"65","author":"Mackenzie","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.049171_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.112.049171_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/mol.110.069336","article-title":"The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution","volume":"79","author":"MacKenzie","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.112.049171_bib21","doi-asserted-by":"crossref","first-page":"36205","DOI":"10.1074\/jbc.M807961200","article-title":"Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase","volume":"283","author":"Mackenzie","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.049171_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/abbi.1998.0750","article-title":"Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum","volume":"356","author":"Meech","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.112.049171_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/03602530903205823","article-title":"UGT3A: novel UDP-glycosyltransferases of the UGT superfamily","volume":"42","author":"Meech","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.112.049171_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.onc.1209375","article-title":"Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer","volume":"25","author":"Nagar","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/dmd.112.049171_bib25","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1124\/dmd.108.024596","article-title":"Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene","volume":"37","author":"Olson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.049171_bib26","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1073\/pnas.85.8.2444","article-title":"Improved tools for biological sequence comparison","volume":"85","author":"Pearson","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.049171_bib27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0090-9556(24)15084-2","article-title":"O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9","volume":"28","author":"Ren","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.049171_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/FPC.0b013e3283330767","article-title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","volume":"19","author":"Sneitz","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.112.049171_bib29","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1124\/dmd.107.017145","article-title":"Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases","volume":"35","author":"Sun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.049171_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0165-6147(90)90008-V","article-title":"UDP-glucuronosyltransferases: a family of detoxifying enzymes","volume":"11","author":"Tephly","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.112.049171_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624096740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624096740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.049171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:07:00Z","timestamp":1739905620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624096740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0090955624096740"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.049171","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of UDP-Glucuronosyltransferases 2A2 and 2A3 in Tobacco Carcinogen Metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.049171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}